Emergent Biosolutions EBS Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	2.78B	2.74B	2.91B	3.17B	2.95B	2.18B	1.89B	1.82B
Total Current Assets	1.1B	1.08B	1.12B	1.21B	1.22B	777.7M	720.8M	679.5M
Cash and Equivalents	435.8M	358.1M	240.9M	642.6M	430.2M	88.6M	87.8M	111.7M
Total Non-Current Assets	2.49B	2.45B	2.6B	2.77B	2.45B	1.8B	1.57B	1.53B
Total Liabilities	1.21B	1.22B	1.46B	1.78B	1.75B	1.22B	1.2B	1.17B
Total Current Liabilities	249.2M	276.7M	268.4M	1.23B	1.22B	693.2M	664M	651.3M
Total Non-Current Liabilities	1.76B	1.74B	2.22B	1B	979.2M	977.3M	980.1M	969.1M
Common Equity	100k	100k	100k	100k	100k	100k	100k	100k
Retained Earnings	954.1M	897.7M	822M	734M	551M	289.7M	27.7M	-21.8M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	970.11M	1.07B	2.23B	2.33B	2.88B	2.96B	3.17B	1.82B
Total Current Assets	510.22M	485.39M	620.8M	686.2M	1.2B	1.27B	1.21B	679.5M
Cash and Equivalents	271.51M	178.29M	112.2M	167.8M	621.3M	576.1M	642.6M	111.7M
Total Non-Current Assets	596.21M	912.35M	1.01B	1.09B	1.45B	1.62B	1.38B	649.3M
Total Liabilities	373.91M	157.86M	1.22B	1.24B	1.44B	1.34B	1.78B	1.17B
Total Current Liabilities	105.86M	100.07M	200.4M	216.3M	384.5M	373.8M	1.23B	651.3M
Total Non-Current Liabilities	516.14M	71.25M	1.8B	1.82B	1.89B	1.78B	1B	969.1M
Total Equity	596.21M	912.35M	1.01B	1.09B	1.45B	1.62B	1.38B	649.3M
Common Equity	41k	50k	100k	100k	100k	100k	100k	100k
Retained Earnings	254.48M	337.07M	367.3M	421.8M	726.9M	957.8M	734M	-21.8M